Religare Enterprises Ltd
Religare Enterprise Ltd, incorporated in 1984, is a diversified financial services company with presence all over India, operating through its subsidiaries. The Co. provides loans to SMEs, Affordable Housing Finance, Health Insurance and Retail Broking. REL’s subsidiaries service over 11 lakh clients from over 1,275 locations having presence in more than 400 cities.[1][2]
- Market Cap ₹ 7,577 Cr.
- Current Price ₹ 228
- High / Low ₹ 314 / 197
- Stock P/E 73.7
- Book Value ₹ 87.3
- Dividend Yield 0.00 %
- ROCE 8.39 %
- ROE 5.15 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 2.62 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 30.3%
- Company has a low return on equity of 4.12% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,361 | 4,128 | 4,895 | 3,709 | 2,675 | 2,371 | 2,384 | 2,513 | 3,227 | 4,679 | 6,266 | 7,385 | 8,023 | |
| 1,585 | 2,006 | 3,710 | 1,659 | 2,841 | 3,005 | 2,341 | 2,235 | 3,592 | 4,196 | 5,898 | 7,029 | 7,803 | |
| Operating Profit | 1,775 | 2,122 | 1,184 | 2,050 | -167 | -634 | 43 | 278 | -364 | 483 | 368 | 356 | 220 |
| OPM % | 53% | 51% | 24% | 55% | -6% | -27% | 2% | 11% | -11% | 10% | 6% | 5% | 3% |
| 25 | 58 | 1,012 | -316 | 60 | 10 | -157 | 17 | 137 | 3,473 | 263 | 12 | 47 | |
| Interest | 1,584 | 1,658 | 1,879 | 1,840 | 1,271 | 854 | 855 | 733 | 750 | 641 | 112 | 63 | 32 |
| Depreciation | 34 | 37 | 36 | 31 | 30 | 26 | 61 | 59 | 53 | 56 | 72 | 62 | 53 |
| Profit before tax | 182 | 485 | 282 | -136 | -1,407 | -1,504 | -1,030 | -497 | -1,031 | 3,259 | 448 | 243 | 182 |
| Tax % | 85% | 34% | 79% | -10% | -16% | -0% | 1% | -4% | 49% | 3% | 22% | 25% | |
| 27 | 321 | 61 | -124 | -1,181 | -1,501 | -1,038 | -478 | -1,539 | 3,169 | 347 | 183 | 129 | |
| EPS in Rs | -4.63 | 8.62 | -2.67 | -9.77 | -58.56 | -59.33 | -36.12 | -19.60 | -48.43 | 95.24 | 7.06 | 3.79 | 3.12 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 25% |
| 3 Years: | 32% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 17% |
| 3 Years: | 28% |
| TTM: | 248% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 19% |
| 3 Years: | 12% |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 150 | 178 | 178 | 178 | 178 | 217 | 258 | 259 | 319 | 324 | 330 | 331 | 331 |
| Reserves | 2,982 | 3,705 | 3,660 | 2,549 | 1,658 | 616 | -157 | -306 | -1,301 | 1,734 | 2,013 | 2,185 | 2,575 |
| 14,073 | 16,491 | 20,247 | 14,956 | 9,945 | 6,717 | 5,356 | 4,940 | 4,878 | 841 | 443 | 233 | 319 | |
| 3,920 | 5,064 | 3,344 | 3,355 | 2,081 | 2,023 | 2,673 | 3,832 | 5,467 | 5,193 | 6,686 | 8,480 | 9,280 | |
| Total Liabilities | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 | 12,505 |
| 1,981 | 2,128 | 1,785 | 103 | 80 | 83 | 175 | 117 | 127 | 196 | 161 | 145 | 137 | |
| CWIP | 12 | 4 | 4 | 12 | 11 | 14 | 13 | 12 | 2 | 5 | 6 | 8 | 0 |
| Investments | 3,344 | 4,363 | 2,700 | 1,983 | 1,197 | 1,438 | 2,023 | 3,190 | 3,836 | 5,094 | 6,718 | 8,700 | 9,924 |
| 15,788 | 18,944 | 22,941 | 18,940 | 12,574 | 8,038 | 5,919 | 5,406 | 5,397 | 2,797 | 2,587 | 2,376 | 2,444 | |
| Total Assets | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 | 12,505 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,634 | -706 | -2,154 | 5,871 | 5,802 | 3,555 | 2,433 | 1,373 | 1,596 | 1,506 | 1,500 | 1,572 | |
| -403 | -612 | 499 | 2,149 | -457 | -31 | -436 | -1,181 | -689 | -939 | -1,348 | -1,185 | |
| -1,400 | 1,094 | 1,853 | -7,696 | -6,455 | -3,819 | -1,743 | -314 | 559 | -2,079 | -156 | -285 | |
| Net Cash Flow | -169 | -224 | 198 | 324 | -1,110 | -295 | 254 | -122 | 1,466 | -1,512 | -4 | 102 |
| Free Cash Flow | 1,601 | -732 | -2,202 | 5,847 | 5,776 | 3,522 | 2,410 | 1,355 | 1,557 | 1,466 | 1,479 | 1,547 |
| CFO/OP | 93% | -30% | -173% | 287% | -3,525% | -565% | 5,635% | 497% | -438% | 312% | 407% | 441% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Working Capital Days | -303 | -326 | -257 | -187 | -250 | -224 | -267 | -264 | -387 | -275 | -291 | -334 |
| ROCE % | 11% | 11% | 9% | 10% | -1% | -7% | -0% | 4% | -6% | 16% | 9% | 8% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Care Health - Gross Written Premium (GWP) - N Basis Rs. Cr. ・Standalone data |
|
||||||
| Religare Housing (RHDFCL) - Assets Under Management (AUM) Rs. Cr. ・Standalone data |
|||||||
| Care Health - Hospital Network Number ・Standalone data |
|||||||
| Religare Broking (RBL) - Active Clients Lakh ・Standalone data |
|||||||
| Religare Broking (RBL) - E-Governance Agent Network Number ・Standalone data |
|||||||
| Care Health - Retail Health Market Share among SAHI % ・Standalone data |
|||||||
| Religare Finvest (RFL) - Collection Efficiency % ・Standalone data |
|||||||
| Religare Housing (RHDFCL) - Collection Efficiency % ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
General Updates
8 May - RHDFCL appoints Pankaj Rathi as Additional Director and Executive Director-CFO effective April 6, 2026.
-
General Updates
8 May - Religare Finvest appoints Srinivasan Karthik as CEO and additional director, subject to RBI and shareholder approvals.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7 May - Of Analyst call to be held on May 13, 2026 at 04:00 P.M.
-
General Announcement
7 May - CHIL received rectification order on May 4, 2026, reducing tax liability from Rs 89.02 crore to Rs 45.16 crore.
-
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015 & Closure Of Trading Window
7 May - Board meeting on May 12, 2026 to approve audited FY26 results; trading window closed till May 14.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Services
A)Lending (15% of the revenue in FY21) Lending and Investments, Financial Advisory Services, Distribution of Third-Party Financial Products. The Co. provides SME Finance through Religare Finvest Ltd.(RFL) and Affordable Housing Finance through Religare Housing Development Finance Corporation Ltd.(RHDFCL)
B)Health Insurance (74.5% of the revenue) Offers products in the retail segment for Health Insurance, Critical Illness, Personal Accident, Top-up Coverage, International Travel Insurance and Maternity along with Group Health Insurance and Group Personal Accident Insurance for corporates through Care Health Insurance Limited (formerly known as Religare Health Insurance Co. Ltd.)[1]
C)Retail Broking (8.5% of the revenue)Broking in Securities and Commodities, Custodial and Depository Operations, PMS, Institutional Equities and Investment Banking Services through Religare Broking Ltd.[2] [3]